Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank 144a Regulatory News (AXBA)

Share Price Information for Axis Bank 144a (AXBA)

Share Price is delayed by 15 minutes
Get Live Data
40.9145    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $25.45b
AXBA Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank 144a Share Chart

Notes Allotment Intimation

8 Sep 2021 14:17

RNS Number : 1559L
Axis Bank Limited
08 September 2021
 

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED

STATES OF AMERICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL

 

AXIS/CO/CS/274/2021-22

 

September 8, 2021

Dear Sir(s),

 

Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the "Listing Regulations")

 

This is with reference to our letter no. AXIS/CO/CS/251/2021-22 dated August 30, 2021, wherein we had informed that the Bank has initiated the process of issuing of the debt instruments in the form of the Additional Tier 1 Notes in foreign currency, subject to market conditions. We also refer to our letter no. AXIS/CO/CS/262/2021-22 dated September 2, 2021, wherein we had informed that the Bank, acting through its GIFT City branch, has completed the pricing of its U.S. dollar denominated Basel III compliant Additional Tier 1 Notes (the "Notes").

 

We are pleased to inform that the Bank has raised USD 600,000,000 through the issue and allotment of USD denominated, unsecured, 4.10% Basel III compliant, Additional Tier 1 Notes (i) to qualified institutional buyers (as defined in Rule 144A under the United States Securities Act of 1933, as amended (the "U.S. Securities Act")) and (ii) outside the United States in offshore transactions in compliance with Regulation S under the U.S. Securities Act.

 

The Notes will be listed on Singapore Exchange Limited, International Securities Market, India International Exchange (IFSC) Limited and the NSE IFSC Limited (NSE International Exchange).

 

This is for information of all concerned, in compliance with the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

 

Thanking you,

 

Yours sincerely,

For Axis Bank Limited

 

 

 

Girish V. Koliyote

Company Secretary

 

DISCLAIMER

 

The Offering Circular ("OC") for the GMTN programme has not been and will not be registered or filed or published as a prospectus or a statement in lieu of a prospectus with the Registrar of Companies ("RoC"), the Securities and Exchange Board of India ("SEBI") or any other statutory or regulatory body of like nature in India in respect of a public offer or information memorandum or other offering material in respect of any private placement of securities under the Companies Act, 2013, as amended, and the rules framed thereunder or any other applicable Indian laws.

 

The OC has not been and will not be reviewed or approved by any regulatory authority in India, including, but not limited to, the SEBI, the RoC, the Reserve Bank of India, or any stock exchange in India. This OC and the Additional Tier 1 Notes ("Notes") are not and should not be construed as an advertisement, invitation, offer or sale of any securities to the public or any person resident in India.

 

The Notes have not been and will not be, offered or sold to any person resident in India.

 

This information relates to an offering of the Notes to be offered and sold (i) to qualified institutional buyers (as defined in Rule 144A under the United States Securities Act of 1933, as amended (the "U.S. Securities Act")) and (ii) outside the United States in offshore transactions in compliance with Regulation S under the U.S. Securities Act. This information is not an offer of securities for sale in the United States. The Notes referred to herein have not been and will not be registered under the U.S. Securities Act or the laws of any state of the United States or elsewhere and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws of the United States. There is no intention to register any portion of any offering in the United States or to conduct a public offering of securities in the United States or in any other jurisdiction. Nothing in this communication shall constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction in which such offer or sale would be unlawful. No money, securities or other consideration is being solicited by this announcement or the information contained herein and, if sent in response to this announcement or the information contained herein, will not be accepted.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEADNPEFLFEFA
Date   Source Headline
28th Apr 202611:22 amRNSUpdate
28th Apr 202611:20 amRNSChange in SMP
28th Apr 202611:20 amRNSGeneral Update
28th Apr 202611:17 amRNSResults
28th Apr 202611:17 amRNSInvestor Presentation and Press Release
28th Apr 202611:16 amRNSDividend and Fund Raising
28th Apr 202611:13 amRNSAGM Update
4th Feb 202612:09 pmRNSMarket Rumour Verification
27th Jan 202610:48 amRNSOutcome of Board Meeting
26th Jan 20267:52 amRNSResults
19th Jan 20261:45 pmRNSResult of Postal Ballot
14th Jan 20269:55 amRNSGrant of Stock Options
29th Dec 20257:00 amRNSUpdate to the Global Medium Term Notes Programme
29th Dec 20257:00 amRNSUpdate to the Global Medium Term Notes Programme
19th Dec 20257:00 amRNSPostal Ballot Notice
19th Dec 20257:00 amRNSPostal Ballot Notice
18th Dec 20257:00 amRNSChange in Director
26th Nov 20251:32 pmRNSNCD Allotment
26th Nov 20251:13 pmRNSCHANGES IN SENIOR MANAGEMENT - CHIEF RISK OFFICER
26th Nov 20251:11 pmRNSNCD Issuance
15th Oct 20253:08 pmRNSGDR Policy
15th Oct 202511:38 amRNSResults
3rd Oct 20251:31 pmRNSPrior Intimation of Board Meeting
4th Aug 20257:00 amRNSDirectorate Change
25th Jul 20253:11 pmRNSPost AGM intimation
24th Jul 20254:04 pmRNSRevision in Vesting period
18th Jul 20259:18 amRNSChange in Management
17th Jul 202511:57 amRNSResults Q1FY26
16th Jul 20259:38 amRNSESOP Grant
2nd Jul 20252:03 pmRNSBoard Meeting Prior Intimation
27th Jun 20251:16 pmRNSPenalty
27th Jun 20257:25 amRNSBRSR
27th Jun 20257:24 amRNSNotice And Integrated Annual Report
5th Jun 20252:55 pmRNSChange in Director
2nd May 20254:17 pmRNSPostal Ballot Results and Scrutinizers Report
25th Apr 20251:52 pmRNSOutcome of Board Meeting
25th Apr 20251:49 pmRNSChange in Management
24th Apr 20252:25 pmRNSOutcome of Board Meeting
24th Apr 20252:23 pmRNSAnnual Financial Results FY25
15th Apr 20256:26 pmRNSPrior Intimation of Board Meeting
2nd Apr 202510:17 amRNSPostal Ballot Notice
13th Feb 202512:52 pmRNSChange in SMP
13th Feb 202512:49 pmRNSRBI Penalty
3rd Feb 20257:00 amRNSChange in vesting period
31st Jan 20252:24 pmRNSChange in Management
17th Jan 20252:46 pmRNSChange in Management
16th Jan 202511:02 amRNSMiscellaneous (Financial Results Q3FY25)
7th Jan 20257:00 amRNSIntimation of Board Meeting
27th Nov 20245:12 pmRNSIntimation wrt SEBI Interim Order Confirmatory
20th Nov 20247:00 amRNSRating Action by CRISIL

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.